Il y a eu 50 transactions d'initiés récentes enregistrées pour HCA Healthcare, Inc. (HCA), dont 13 achats et 29 ventes. Le total des achats d'initiés s'élève à $54.59M et le total des ventes d'initiés à $58.8M.
Les initiés notables ayant une activité récente comprennent Mcalevey Michael R, Wyatt Christopher F., Berres Jennifer. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — HCA
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-02-18 |
Mcalevey Michael R |
EVP & Chief Legal & Admin Off. |
Vente Informative |
1,694 |
$533.38 |
$903.54K |
8,853 |
| 2026-02-13 |
Mcalevey Michael R |
EVP & Chief Legal & Admin Off. |
Exercice d'Options (Vente) |
5,000 |
$236.61 |
$1.18M |
8,860 |
| 2026-02-11 |
Wyatt Christopher F. |
SVP & Controller |
Vente Informative |
4,000 |
$505.00 |
$2.02M |
44,379 |
| 2026-02-11 |
Berres Jennifer |
SVP & Chief Human Res. Officer |
Vente Informative |
4,010 |
$526.17 |
$2.11M |
11,993 |
| 2026-02-10 |
Hazen Samuel N |
CEO |
Retenue Fiscale RSU |
21,323 |
$502.05 |
$10.71M |
64,842 |
| 2026-02-10 |
Foster Jon M |
EVP and COO |
Retenue Fiscale RSU |
5,888 |
$502.05 |
$2.96M |
23,062 |
| 2026-02-10 |
Cuffe Michael S. |
EVP and Chief Clinical Officer |
Retenue Fiscale RSU |
3,501 |
$502.05 |
$1.76M |
32,080 |
| 2026-02-10 |
Wyatt Christopher F. |
SVP & Controller |
Retenue Fiscale RSU |
1,034 |
$502.05 |
$519.12K |
48,379 |
| 2026-02-10 |
Berres Jennifer |
SVP & Chief Human Res. Officer |
Retenue Fiscale RSU |
2,515 |
$502.05 |
$1.26M |
20,013 |
| 2026-02-10 |
Mcalevey Michael R |
EVP & Chief Legal & Admin Off. |
Retenue Fiscale RSU |
3,006 |
$502.05 |
$1.51M |
8,853 |
| 2026-02-10 |
Marks Mike A |
EVP and CFO |
Retenue Fiscale RSU |
1,690 |
$502.05 |
$848.46K |
3,336 |
| 2026-02-10 |
Rossitto Erica |
SVP & Chief Nurse Executive |
Retenue Fiscale RSU |
418 |
$502.05 |
$209.86K |
10,407 |
| 2026-02-06 |
Frist Thomas F Jr |
10 Percent Owner |
Autre (Vente) |
36,629,188 |
$0.01 |
$366.29K |
- |
| 2026-02-06 |
Frist Thomas F Iii |
10 Percent Owner |
Autre (Vente) |
36,629,188 |
$0.01 |
$366.29K |
- |
| 2026-02-06 |
Hercules Holding Ii |
10 Percent Owner |
Autre (Vente) |
36,629,188 |
- |
- |
32,282,889 |
| 2026-02-06 |
Frisco Holding Ii |
10 Percent Owner |
Autre (Vente) |
36,629,188 |
$0.01 |
$366.29K |
- |
| 2026-02-06 |
Elcan Patricia F |
10 Percent Owner |
Autre (Vente) |
36,629,188 |
$0.01 |
$366.29K |
- |
| 2026-02-06 |
Frist William R |
10 Percent Owner |
Autre (Vente) |
36,629,188 |
$0.01 |
$366.29K |
- |
| 2026-02-05 |
Foster Jon M |
EVP and COO |
Exercice d'Options (Vente) |
29,330 |
$139.06 |
$4.08M |
- |
| 2026-02-05 |
Wyatt Christopher F. |
SVP & Controller |
Exercice d'Options (Vente) |
10,670 |
$139.06 |
$1.48M |
- |
| 2026-02-04 |
Hazen Samuel N |
CEO |
Autre (Achat) |
1,045 |
$498.35 |
$520.78K |
16,024 |
| 2026-02-03 |
Hazen Samuel N |
CEO |
Vente Informative |
120 |
$497.18 |
$59.66K |
32,276 |
| 2026-02-03 |
Cuffe Michael S. |
EVP and Chief Clinical Officer |
Don (Donné) |
4,050 |
- |
- |
25,953 |
| 2026-02-01 |
Rossitto Erica |
SVP & Chief Nurse Executive |
Inconnu |
960 |
$130.56 |
$125.34K |
- |
| 2026-01-30 |
Hazen Samuel N |
CEO |
Exercice d'Options (Vente) |
84,360 |
$81.96 |
$6.91M |
- |
| 2026-01-29 |
Hazen Samuel N |
CEO |
Attribution de RSU |
55,846 |
$482.53 |
$26.95M |
55,846 |
| 2026-01-29 |
Foster Jon M |
EVP and COO |
Attribution de RSU |
11,945 |
$482.53 |
$5.76M |
11,945 |
| 2026-01-29 |
Cuffe Michael S. |
EVP and Chief Clinical Officer |
Attribution de RSU |
8,067 |
$482.53 |
$3.89M |
8,067 |
| 2026-01-29 |
Wyatt Christopher F. |
SVP & Controller |
Attribution de RSU |
2,560 |
$482.53 |
$1.24M |
2,560 |
| 2026-01-29 |
Berres Jennifer |
SVP & Chief Human Res. Officer |
Attribution de RSU |
6,206 |
$482.53 |
$2.99M |
6,206 |
| 2026-01-29 |
Mcalevey Michael R |
EVP & Chief Legal & Admin Off. |
Attribution de RSU |
8,067 |
$482.53 |
$3.89M |
8,067 |
| 2026-01-29 |
Marks Mike A |
EVP and CFO |
Attribution de RSU |
11,945 |
$482.53 |
$5.76M |
11,945 |
| 2025-11-14 |
Hazen Samuel N |
CEO |
Don (Donné) |
14,830 |
- |
- |
32,276 |
| 2025-11-05 |
Mcalevey Michael R |
EVP & Chief Legal & Admin Off. |
Vente Informative |
3,892 |
$473.79 |
$1.84M |
3,487 |
| 2025-11-05 |
Marks Mike A |
EVP and CFO |
Don (Donné) |
165 |
- |
- |
- |
| 2025-11-03 |
Mcalevey Michael R |
EVP & Chief Legal & Admin Off. |
Exercice d'Options (Vente) |
13,170 |
$236.61 |
$3.12M |
- |
| 2025-11-03 |
Marks Mike A |
EVP and CFO |
Don (Reçu) |
165 |
- |
- |
165 |
| 2025-10-31 |
Hazen Samuel N |
CEO |
Exercice d'Options (Vente) |
58,050 |
$69.58 |
$4.04M |
- |
| 2025-09-08 |
Cuffe Michael S. |
EVP and Chief Clinical Officer |
Vente Informative |
3,836 |
$418.84 |
$1.61M |
31,503 |
| 2025-09-04 |
Cuffe Michael S. |
EVP and Chief Clinical Officer |
Exercice d'Options (Vente) |
10,920 |
$173.12 |
$1.89M |
10,000 |
| 2025-07-29 |
Chidsey John |
Director |
Attribution de RSU |
496 |
- |
- |
496 |
| 2025-07-15 |
Chidsey John |
Director |
Inconnu |
- |
- |
- |
3 |
| 2025-05-13 |
Hazen Samuel N |
CEO |
Don (Donné) |
90,076 |
- |
- |
- |
| 2025-05-13 |
Foster Jon M |
EVP and COO |
Autre (Vente) |
15,925 |
$367.20 |
$5.85M |
- |
| 2025-05-07 |
Marks Mike A |
EVP and CFO |
Autre (Vente) |
285 |
$356.84 |
$101.7K |
- |
| 2025-05-06 |
Marks Mike A |
EVP and CFO |
Don (Donné) |
144 |
- |
- |
144 |
| 2025-04-30 |
Frist William R |
10 Percent Owner |
Autre (Achat) |
10,505 |
$340.60 |
$3.58M |
1,574,897 |
| 2025-04-29 |
Deparle Nancy Ann |
Director |
Attribution de RSU |
645 |
- |
- |
21,401 |
| 2025-04-29 |
Michelson Michael W |
Director |
Attribution de RSU |
1,173 |
- |
- |
11,651 |
| 2025-04-29 |
Frist Thomas F Iii |
10 Percent Owner |
Attribution de RSU |
1,320 |
- |
- |
14,817 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
